NCT06412315View on ClinicalTrials.gov

7T Amygdala and Citalopram Study

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 13, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Emotional ProcessingCognitionMood DisordersDepressive DisorderDepression
Interventions
DRUG

Citalopram

Participants will receive a single dose (20mg) citalopram. Tablets encapsulated to aid blinding. To take per oral once.

DRUG

Placebo

Participants will receive a single dose of placebo (sucrose). Tablets encapsulated to aid blinding. To take per oral once

Trial Locations (1)

OX37JX

RECRUITING

University of Oxford, Department of Psychiatry, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER